GlaxoSmithKline Signs $2.2 Billion Vaccine Deal with Brazil

Reuters -- GlaxoSmithKline Plc sealed a 1.5 billion euro ($2.2 billion) deal with Brazil guaranteeing sales of its pneumococcal vaccine for 10 years, the company said on Monday.